SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001559515-20-000001
Filing Date
2020-05-15
Accepted
2020-05-15 16:46:03
Documents
1
Period of Report
2020-05-13

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 4  
1 PRIMARY DOCUMENT primary_doc.xml 4 3314
  Complete submission text file 0001559515-20-000001.txt   4937
Mailing Address 10 HUDSON YARDS, 37TH FLOOR New York NY 10001
Business Address 10 HUDSON YARDS, 37TH FLOOR NEW YORK NY 10001 646-747-1000
INTERCEPT PHARMACEUTICALS, INC. (Issuer) CIK: 0001270073 (see all company filings)

IRS No.: 223868459 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address VIA G. DE GRASSI, 11 MILAN L6 20123
Business Address VIA G. DE GRASSI, 11 MILAN L6 20123 390236515110
Genextra S.p.A. (Reporting) CIK: 0001559515 (see all company filings)

State of Incorp.: L6 | Fiscal Year End: 1212
Type: 4 | Act: 34 | File No.: 001-35668 | Film No.: 20886217